Ernexa Therapeutics (ERNAW) Goodwill & Intangibles (2010 - 2026)

Ernexa Therapeutics has reported Goodwill & Intangibles for 17 years, with the latest figure at $2.0 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill & Intangibles fell 2.15% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (down 2.15% YoY), and the FY2025 full-year result was $2.0 million, changed 0.0% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $2.0 million, down from $2.0 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $8.0 million in Q1 2022, with the low at $2.0 million in Q3 2022.
• Historically, Goodwill & Intangibles has averaged $2.4 million across 5 years, with a median of $2.0 million in 2022.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles slumped 75.11% — and 2023, when it gained 2.2%.
• Ernexa Therapeutics' Goodwill & Intangibles stood at $2.0 million in 2022, then rose by 2.2% to $2.0 million in 2023, then changed by 0.0% to $2.0 million in 2024, then changed by 0.0% to $2.0 million in 2025, then fell by 2.15% to $2.0 million in 2026.
• The last three Goodwill & Intangibles figures came in at $2.0 million (Q1 2026), $2.0 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.